Related Experiment Video
Updated: Nov 28, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Cost Impact of a Pharmacist-Driven Medication Reconciliation Program during Transitions to Long-Term Care and
Denis O'Donnell1, Carla Beaton2, June Liang3
1Director of clinical research at Medical Pharmacies Group Limited in Markham, ON. Denis can be reached by e-mail at dodonnell@medicalpharmacies.com.
Abstract:
The current provincial funding model in Ontario, Canada, does not offer dedicated funding to drive medication reconciliation (MedRec) programs during transitions into long-term care and retirement homes. This economic analysis aimed to estimate potential cost savings attributed to hospitalizations averted and decreases in polypharmacy by a MedRec program from a healthcare payer perspective. From a pool of 6,678 pharmacist recommendations, a limited sample of recommendations targeting specific medication-related adverse events showed potential savings of $622.35 per patient from hospital admissions avoided and of $1,414.52 per patient per year from medication discontinuations. Pharmacist-driven MedRec, conducted virtually, delivers substantial healthcare savings.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

